We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current KAYS market cap is 835.92k. The company's latest EPS is USD 0.0726 and P/E is 0.55.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.01M | 1.03M | 890k | 685k | 196k |
| Operating Income | -2.27M | -1.75M | -1.43M | -1.71M | -1.24M |
| Net Income | 7.8M | -12.1M | 9.72M | -3.58M | 1.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.66M | 2.3M | 1.57M | 843k | 216k |
| Total Liabilities | 16.15M | 27.23M | 15.98M | 18.45M | 15.97M |
| Total Equity | -13.49M | -24.93M | -14.41M | -17.6M | -15.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -775k | -290k | 10.66M | -919k | -1.05M |
| Investing | -20k | -32k | 1.27M | 17k | 813k |
| Financing | 770k | 278k | 296k | 370k | 245k |
| Market Cap | 835.92k |
| Price to Earnings Ratio | 0.55 |
| Price to Sales Ratio | 4.55 |
| Price to Cash Ratio | 30.77 |
| Price to Book Ratio | -0.06 |
| Dividend Yield | - |
| Shares Outstanding | 22.17M |
| Average Volume (1 week) | 1.25k |
| Average Volume (1 Month) | 5.41k |
| 52 Week Change | -23.06% |
| 52 Week High | 0.054 |
| 52 Week Low | 0.0272 |
| Spread (Intraday) | 0.01 (29.4%) |
| Company Name | Kaya Holdings Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.kayaholdings.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
